… . Tadross is a fourth-year medical student at the University of … Miami Miller School of Medicine. Dr. Williams is an associate … . Solitary retinal capillary hemangioma: Hereditary (von Hippel-Lindau disease) or nonhereditary? Arch Ophthalmol 2001 …

… ) have been published in Nature Medicine, reinforcing pembrolizumab (Keytruda) plus … to be positively linked with von Hippel-Lindau tumor suppressor gene (P = .040 … treatment. News release. Vanderbilt University Medical Center. August 1, 2025. Accessed …

Patients with von Hippel-Lindau (VHL) disease are predisposed to … . This study evaluated disease monitoring and treatment patterns … drug use, disease monitoring procedures, and medical specialist visits in … .61]), and visited more medical specialists (1.82 [95% …

… understanding the natural history of von Hippel-Lindau (VHL) disease-associated renal cell carcinoma … of surgery, including chronic kidney disease (CKD), and mortality. Radiographic … patients, with high rates of disease progression, surgery, and metastasis …

… belzutifan as systemic treatment for von Hippel-Lindau disease-associated renal cell carcinoma. … of the National Institutes of Health, National Cancer Institute Center … Boston, MA, USA., Vanderbilt University Medical Center, Nashville, TN, USA., University …

… rheumatoid arthritis9–11. Neurological disorders feature TFs controlling neural … approved in 2021 for von Hippel-Lindau (VHL) disease 24. This breakthrough demonstrates … combination therapies and precision medicine. Artificial intelligence is accelerating …

… data on belzutifan for von Hippel-Lindau (VHL) disease, and Phase II clinical … Hematology-Oncology and of Medical Ethics and Health Policy, will present … Hospital, Doylestown Health, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania …

… monotherapy for certain patients with von Hippel-Lindau (VHL) disease and renal cell carcinoma … in 2020 alone. The disease disproportionately affects men and approximately … recommendation from the European Medicines Agency’s human medicines committee and was …

… -phenotype correlations in patients with Von Hippel-Lindau (VHL) disease. We retrospectively studied 53 … , Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo … , Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo …

… Canada, announced that the National Medical Products Administration (NMPA) in China … and in combination with other medicines. LITESPARK-004 is an open … and CNS hemangioblastomas. Von Hippel-Lindau disease is a rare genetic disease that impacts an …